Keyphrases
United States
100%
Standard of Care
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Cost-effectiveness
100%
Type I Diabetes
100%
Automated Insulin Delivery
100%
Tubeless
100%
Non-severe Hypoglycemia
60%
Quality-adjusted
40%
Treatment Effect
20%
Incremental Cost-effectiveness Ratio
20%
Probabilistic Sensitivity Analysis
20%
Payer Perspective
20%
Children with Type 1 Diabetes
20%
Risk Factors
10%
Clinical Trials
10%
National Database
10%
Treatment Options
10%
Treatment Duration
10%
Willingness-to-pay Threshold
10%
Single-arm Study
10%
Care Delivery
10%
Simulated Patient
10%
Glycated Hemoglobin A1c
10%
Analysis Sensitivity
10%
Treatment Costs
10%
Cost-effectiveness Analysis
10%
A1c Levels
10%
Severe Hypoglycemia
10%
Diabetes Costs
10%
Incremental Cost
10%
Current Analysis
10%
Ketoacidosis
10%
Cost-effective Treatment
10%
Diabetes Complications
10%
Continuous Subcutaneous Insulin Infusion
10%
Time in Range
10%
Multiple Daily Injections
10%
Treating children
10%
Omnipod
10%
IQVIA Core Diabetes Model
10%
Effect Thresholds
10%
Medicine and Dentistry
Cost-Effectiveness Analysis
100%
Insulin Dependent Diabetes Mellitus
100%
Health Care Cost
87%
Hypoglycemia
87%
Diabetes
25%
Treatment Effect
25%
Clinical Trial
12%
Arm
12%
Hemoglobin A1c
12%
Insulin Infusion
12%
Treatment Duration
12%
Ketoacidosis
12%
Patient with Type 1 Diabetes
12%
Insulin Pump
12%
Nursing and Health Professions
Cost Effectiveness Analysis
100%
Health Care Quality
100%
Insulin Dependent Diabetes Mellitus
100%
Hypoglycemia
87%
Incremental Cost-Effectiveness Ratio
25%
Hemoglobin A1c
12%
Patient with Type 1 Diabetes
12%
Treatment Duration
12%
Insulin Infusion
12%
Ketoacidosis
12%
Insulin Pump
12%
Pharmacology, Toxicology and Pharmaceutical Science
Insulin Dependent Diabetes Mellitus
100%
Hypoglycemia
77%
Clinical Trial
11%
Hemoglobin A1c
11%
Ketoacidosis
11%